Insurers’ contracts with doctors, hospitals and pharmaceutical companies (or their arbiters, so-called pharmacy benefit managers) can change abruptly at any time.
One study found that, in 2020, the annual number of U.S. campaigns related to medical causes was 25 times the number of such campaigns on the site in 2011.
The FTC is attacking drugmakers’ ‘patent thickets’
The Federal Trade Commission has challenged the validity of over 100 drug product patents in an effort to increase competition and potentially lower some prices.
Ouch. That ‘free’ annual checkup might cost you. Here’s why.
Following the success of COVID-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus’s structure, putting a host of new vaccines on the horizon.
The shrinking number of primary care physicians is reaching a tipping point
Millions of Americans in the past few years have run into this experience: filing a health care insurance claim that once might have been paid immediately but instead is just as quickly denied.
An AI chatbot may be your next therapist. Will it actually help your mental health?
